Pro Dex Inc (PDEX) stock
Close on Nov 11, 2026Market cap $228.77MP/E 19.7Yield –
Pro Dex Inc grew revenue 13.3% to $79.58M over the twelve months to Sep 30, 2026. Operating income rose 24.2% to $13.40M, moving the operating margin from 15.4% to 16.8%. Free cash flow was $10.69M. At the latest close the market valued the company at $228.77M, 19.7 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $228.77M
- P/E ratio
- 19.7
- Price to sales
- 2.87
- Price to book
- 4.64
- Dividend yield
- –
- Free cash flow yield
- 4.67%
Fundamentals
- Revenue
- $79.58M
- Net income
- $12.03M
- EPS, diluted
- $3.63
- Free cash flow
- $10.69M
- Book value per share
- $14.88
- Diluted shares
- 3M
Trading
- Next earnings
- Jan 28, 2027 (estimated, after the close)
- Previous close
- $69.86
- Open
- $70.99
- Day's range
- $70.55 – $72.00
- Volume
- 34,371
- Average volume (20 days)
- 39,189
- Index membership
- Russell 2000 (since Jun 2025)
- Beta (5 years)
- 0.27
- 52-week range
- $28.81 – $77.00
- RSI (14 days)
- 65.0
- Volatility (1 year)
- 55.9%
- Relative volume
- 0.49×
- WACC
- 7.3%
Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | PDEX | S&P 500 | Difference | PDEX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +14.4% | -2.4% | +16.8 pts | ||
| 3 months | +7.1% | -1.2% | +8.3 pts | ||
| Year to date | +85.8% | +12.3% | +73.5 pts | ||
| 1 year | +112.7% | +12.4% | +100.3 pts | ||
| 3 years | +294.5% | +78.8% | +215.7 pts | +58.0% | +21.4% |
| 5 years | +189.1% | +75.2% | +113.9 pts | +23.7% | +11.9% |
| 10 years | +1488.7% | +311.1% | +1177.6 pts | +31.9% | +15.2% |
Fifteen years at a glance
Fiscal years 2012 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Pro Dex filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Update
- Results
About Pro Dex
Surgical & Medical Instruments & Apparatus
Pro-Dex designs, develops, and manufactures specialized surgical devices, operating as a single business segment. Its core products include autoclavable, electric, and battery-powered multi-function surgical drivers and shavers used in thoracic, orthopedic, and craniomaxillofacial medical procedures. The company also produces rotary air motors, provides non-recurring engineering, consulting, and repair services, and fabricates precision machined components and assemblies for aerospace and defense applications. It primarily serves medical device distributors, original equipment manufacturers, commercial aerospace and defense customers, and the United States government.
Company profile, executives and historyPro Dex stock: common questions
What is Pro Dex's stock price?
PDEX closed at $71.49 on Nov 11, 2026, up 2.33% on the day. Over the past 52 weeks it traded between $28.81 and $77.00.
What is Pro Dex's market cap?
Pro Dex was worth $228.77M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is PDEX's P/E ratio?
PDEX trades at 19.7 times earnings, based on diluted earnings per share of $3.63 over the twelve months to Sep 30, 2026.
How much revenue does Pro Dex make?
Pro Dex reported revenue of $79.58M for the twelve months to Sep 30, 2026, up 13.3% from a year earlier.
Does Pro Dex pay a dividend?
No. Pro Dex has not paid a cash dividend over the last twelve months.
When does Pro Dex report earnings next?
Pro Dex is expected to report Q2 FY2027 results on Jan 28, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has PDEX stock performed over the past year?
Including dividends, PDEX returned +112.7% over the past year, against +12.4% for the S&P 500.
How many PDEX shares are sold short?
0M shares were sold short at the latest FINRA report, 15.62% of the float, or 7.4 days of average trading volume.
Who are Pro Dex's competitors?
Companies most similar to Pro Dex by business, industry and size include RCEL, APYX, TELA, CARL, UTMD.
See a number that looks wrong?